Search results
Results From The WOW.Com Content Network
This famed Sativa strain has THC levels usually ranging from 15% to 20%, making it moderately potent, hence suitable for newbies to the cannabis community. ... Potential pain-relieving effects. 75 ...
Its most common form is the oromucosal spray derived from two strains of Cannabis sativa and containing THC and CBD traded under the brand name Sativex®. [53] It is not approved in the United States, but is approved in several European countries, Canada, and New Zealand as of 2013. [6]
Cannabis plants vary widely, with different strains producing dynamic balances of cannabinoids (THC, CBD, etc.) and yielding markedly different effects. Popular strains are often hybrids of C. sativa and C. indica. The medicinal effects of cannabis are widely studied, and are active topics of research both at universities and private research ...
Cannabis strains is a popular name to refer to plant varieties of the monospecific genus Cannabis sativa L.. They are either pure or hybrid varieties of the plant, which encompasses various sub-species C. sativa , C. indica , and C. ruderalis .
The flowers of Cannabis sativa plants are most often either male or female, but, only plants displaying female pistils can be or turn hermaphrodite. Males can never become hermaphrodites. [ 3 ] It is a short-day flowering plant, with staminate (male) plants usually taller and less robust than pistillate (female or male) plants.
Most strains of Cannabis are short day plants, [16] with the possible exception of C. sativa subsp. sativa var. spontanea (= C. ruderalis), which is commonly described as "auto-flowering" and may be day-neutral.
Strains used in medicine are often bred for high CBD content, and strains used for recreational purposes are usually bred for high THC content or for a specific chemical balance. Quantitative analysis of a plant's cannabinoid profile is often determined by gas chromatography (GC), or more reliably by gas chromatography combined with mass ...
Nabiximols (brand name Sativex), an oromucosal spray made of a complex botanical mixture containing cannabidiol (CBD), delta-9-tetrahydrocannabinol (THC), and additional cannabinoid and non-cannabinoid constituents from cannabis sativa plants, was approved by Health Canada in 2005, to treat central neuropathic pain in multiple sclerosis, and in ...